BioSpace News Archive

ENDRA Life Sciences Inc. announces that the European Patent Office has issued two new patents to ENDRA, European Patent No. 3668382 titled “Method and System for Estimating Fractional Fat Content of an Object” and European Patent No. 3661416 titled “Method for Estimating Fractional Fat Content of an Object.”.

Kintara Therapeutics, Inc. (Nasdaq: KTRA) (“Kintara” or the “Company”), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced financial results for its fiscal second quarter ended December 31, 2021 and provided a corporate update.

Amolyt Pharma, a global company specialized in developing therapeutic peptides for rare endocrine and related diseases, announced that management will be participating at three upcoming investor conferences.

Asymchem Laboratories (Tianjin) Co., Ltd. (stock code: 002821.SZ/6821.HK) (“Asymchem”), a leading CDMO serving the global pharmaceutical and biotech industry, today announced its agreement to acquire Snapdragon Chemistry, Inc.

Vaxxinity, Inc. (Nasdaq: VAXX), today announced results from studies demonstrating the ability of UB-612, its COVID-19 vaccine candidate, to elicit a broad immune response against multiple variants of concern, and specifically more than three-times higher titers of neutralizing antibodies against the Omicron variant of SARS-CoV-2 than an approved mRNA vaccine with boosters.

TC BioPharm plc is pleased to announce that American Depositary Shares representing the Company’s ordinary shares will commence trading on the Nasdaq Capital Market under the ticker symbol “TCBP”.

Passage Bio, Inc. (Nasdaq: PASG), a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous system (CNS) disorders, today presented updated clinical data from Imagine-1, a Phase 1/2 study of PBGM01, a gene therapy for GM1 gangliosidosis (GM1).

According to Emergen Research, the global single-cell sequencing market size was USD 1,294.01 million in 2020 and is expected to reach USD 3,679.65 million in 2028 and register a revenue CAGR of 13.9% during the forecast period, 2021-2028.

The report provides details about market size, market restraints, drivers, challenges, growth opportunities, and top companies in the market.

The industry analysis report is considered a valuable source of information about the global In Vitro Diagnostics (IVD) industry and lays stress on the future market scope, emerging industry trends, industry statistics, and market growth potential during the forecast years.